19 Dec
Member News

EIB at the UN Climate Change Conference – COP 25

As one of the world's biggest providers of climate finance, the European Investment Bank, the EU’s climate bank, took part in the UN Climate Change Conference (COP25), the annual meeting of global leaders and climate action experts. During COP 25, governments came together to discuss the next crucial steps in the UN climate change process. Following agreement on the implementation guidelines of the Paris Agreement at COP 24 in Poland last year, a key objective is to complete several matters with respect...

Read more

19 Dec
Chapter News

EIOPA Identifies Areas where Risks for Consumers Remain High, Notably with Unit-Linked, Credit Life/Credit Protection, and Add-on Insurance Products

The European Insurance and Occupational Pensions Authority (EIOPA) published, today, its 2019 Consumer Trends Report outlining major developments in the insurance and pensions sectors affecting European consumers. Improvements in disclosure practices have been seen and digitalisation remains a broadly noteworthy trend, showing that financial innovations can bring benefits for both insurers and consumers, so long as they are adequately designed and properly implemented. Accident and health insurance products continue being 'good value-for-money', with the medical expense line of business having the highest claims...

Read more

19 Dec
Member News

New European Guidance on the Qualification and Classification of Software as Medical Devices

By Irene Picciano and Elisa Stefanini of Portolano Cavallo Studio Legale In October 2019, the European Commission’s Medical Devices Coordination Group (MDCG) published a new guidance on the qualification and classification of software as medical devices (MDSW) under the new Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulations (IVDR) (the “Guidance”). The Guidance aims at providing clarification to medical software manufacturers with respect to (i) qualification issues (when software is considered a device); and (ii) classification issues, depending on...

Read more

18 Dec
Member News

James D. Rosener and Brent A. Morowitz Interviewed during the Deal Economy Conference

James D. Rosener, partner in the Commercial Department of Pepper and head of the firm's International Practice Group, and Brent A. Morowitz, of counsel in the Corporate and Securities Practice Group of Pepper, were interviewed during The Deal Economy Conference. The conference focused on "Predictions and Perspectives" and explored the most effective strategies for deals and transactions, focusing on the opportunities and challenges facing dealmakers in 2019.  View interview here   Compliments of Pepper Hamilton, a Member of the EACCNY

Read more

17 Dec
Chapter News

European Central Bank Monetary Policy Decisions

December 12 - At today’s meeting the Governing Council of the European Central Bank (ECB) decided that the interest rate on the main refinancing operations and the interest rates on the marginal lending facility and the deposit facility will remain unchanged at 0.00%, 0.25% and -0.50% respectively. The Governing Council expects the key ECB interest rates to remain at their present or lower levels until it has seen the inflation outlook robustly converge to a level sufficiently close to,...

Read more

17 Dec
Member News

Managing Export Controls and Sanctions: It’s About Who You Know and What You Know

If you serve in a managerial or advisory role with a company that has foreign operations, suppliers or customers, several familiar phrases have probably caught your attention more often lately. Do “change to the entity list” and “new sanctions announced” sound familiar? Global policies and norms around the exchange of goods, services and ideas are in flux. Various countries, multinational organizations and multilateral treaties with their own best interests in mind are all attempting to regulate trade between foreign nationals...

Read more

17 Dec
Member News

Germany: EIB Provides Funding of EUR 50 Million to BioNTech as Part of the Investment Plan for Europe

The European Investment Bank (EIB) and BioNTech SE (NASDAQ: BNTX, “BioNTech” or “the Company”) announced today the signing of a contract which provides financing of EUR 50 million to BioNTech SE, an international clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases. BioNTech will use the funds for the research and development, market access and manufacturing development for its most advanced treatments under development. The EU bank’s loan is backed by a guarantee...

Read more

16 Dec
Chapter News

Main Results of the European Council

On 12 December, EU leaders discussed climate change, the EU's long-term budget and external relations, among other issues. On 13 December, they focused on the economic and monetary union and Brexit. Climate change EU leaders endorsed the objective of making the EU climate-neutral by 2050, in line with the Paris Agreement. They underlined that the transition to climate neutrality will bring significant opportunities for economic growth, markets, jobs and technological development. Poland, at this stage, could not commit to implementing this objective, which is why the European Council will come...

Read more

16 Dec
Member News

Vulcan Insight: Analysis of the Latest EU Developments

Impact of Johnson Victory on Ireland The Conservative victory this morning was a clear triumph for Boris Johnson whose line “Get Brexit Done” brought out millions of new Tory voters despite horrendous weather conditions. The decisive nature of the victory has been welcomed in Dublin since it provides the clarity which has been sought for the past 3 years. Speaking this morning in Brussels the Taoiseach congratulated Johnson on his formidable victory and noted; “The next step is to ratify...

Read more

16 Dec
Member News

USTR Announces Additional Exclusions Granted to SEC. 301 List 3 Products

On December 12, 2019, the U.S. Trade Representative (“USTR”) announced that 44 additional HTS provisions and product descriptions will be excluded from the Section 301 trade remedies imposed on Chinese-origin products. The newly announced exclusions all relate to items on China 301 List 3 (the $200 billion trade action) which, unless excluded, are subject to an additional tariff of 25% ad valorem. The list of newly-excluded items (which supplements the exclusions previously granted by the USTR) is provided below. The exclusions...

Read more

«‹495496497498499›»